ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 66 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $15,300 | -15.1% | 16,541 | 0.0% | 0.00% | – |
Q1 2023 | $18,030 | -35.1% | 16,541 | -13.1% | 0.00% | – |
Q4 2022 | $27,787 | +20.8% | 19,032 | -9.5% | 0.00% | – |
Q3 2022 | $23,000 | -28.1% | 21,032 | +10.5% | 0.00% | – |
Q2 2022 | $32,000 | -30.4% | 19,032 | -14.4% | 0.00% | – |
Q1 2022 | $46,000 | -43.9% | 22,232 | +1.5% | 0.00% | – |
Q4 2021 | $82,000 | +134.3% | 21,906 | +223.4% | 0.00% | – |
Q3 2021 | $35,000 | -84.1% | 6,774 | -86.9% | 0.00% | – |
Q2 2021 | $220,000 | +158.8% | 51,729 | +222.2% | 0.00% | – |
Q1 2021 | $85,000 | +2733.3% | 16,057 | +3150.4% | 0.00% | – |
Q4 2020 | $3,000 | -40.0% | 494 | -19.7% | 0.00% | – |
Q3 2020 | $5,000 | -98.3% | 615 | -97.9% | 0.00% | -100.0% |
Q2 2020 | $287,000 | +889.7% | 28,621 | +330.8% | 0.00% | – |
Q1 2019 | $29,000 | -74.1% | 6,643 | -66.0% | 0.00% | -100.0% |
Q4 2018 | $112,000 | -17.0% | 19,525 | +95.7% | 0.00% | 0.0% |
Q3 2018 | $135,000 | +309.1% | 9,978 | +261.7% | 0.00% | – |
Q2 2018 | $33,000 | +3200.0% | 2,759 | +1279.5% | 0.00% | – |
Q4 2017 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | – |
Q3 2017 | $2,000 | -88.9% | 200 | -92.0% | 0.00% | – |
Q3 2016 | $18,000 | – | 2,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |